IGI Laboratories To Present At 27th Annual ROTH Capital Conference On March 9, 2015

BUENA, N.J., March 9, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting today at the 27th Annual ROTH Conference. The Conference will take place on March 8-11, 2015 at the Ritz-Carlton, Laguna Niguel, Dana Point, California.

Jason Grenfell-Gardner, CEO and President and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Monday, March 9, 2015 at 10:30 a.m. PT / 1:30 p.m. ET.  

The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.igilabs.com. A replay will be available for 90 days.  

About IGI Laboratories, Inc.
IGI Laboratories is a specialty generic drug development and manufacturing company. Our mission is to be a leading player in the specialty generic prescription drug market.

Logo - http://photos.prnewswire.com/prnh/20130827/MM70487LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/igi-laboratories-to-present-at-27th-annual-roth-capital-conference-on-march-9-2015-300047343.html

SOURCE IGI Laboratories, Inc.

Copyright 2015 PR Newswire